Index/Organizations/semaglutide

semaglutide

Medication used to treat type 2 diabetes and obesity

Fact-Checks

11 results
Jan 13, 2026
Most Viewed

What are the long‑term weight maintenance outcomes after stopping GLP‑1 therapy like semaglutide?

Clinical trials and systematic reviews consistently show that stopping GLP‑1 receptor agonists such as semaglutide is commonly followed by clinically meaningful weight regain — often returning a large...

Jan 18, 2026

How do GLP‑1 and GLP‑1/GIP receptor agonists compare to very low calorie diets in randomized trials measuring drug‑off remission?

Randomized trials show two contrasting pathways to diabetes remission and weight loss: intensive very low calorie diets (VLCDs) can produce drug‑off remission with lasting benefit in protocolized prog...

Jan 16, 2026

What mechanisms link weight loss and GIP/GLP‑1 dual agonism to reduced heart‑failure events in obese patients?

Dual GIP/GLP‑1 agonists like tirzepatide reduce weight and improve multiple cardiometabolic risk factors that plausibly lower heart‑failure events in obese patients, particularly HFpEF, via hemodynami...

Jan 15, 2026

Which weight‑loss supplements have robust, peer‑reviewed clinical evidence and how do their ingredient profiles compare to BurnSlim?

Systematic reviews find that most over‑the‑counter “fat‑burner” supplements produce little or no clinically meaningful weight loss, while a small set of nutraceuticals show modest, peer‑reviewed benef...

Jan 13, 2026

What are the head‑to‑head A1C and weight results for semaglutide versus other GLP‑1RAs and SGLT2 inhibitors?

Randomized trials and pooled analyses show semaglutide delivers larger average reductions in HbA1c and body weight than many other GLP‑1 receptor agonists (GLP‑1RAs), with head‑to‑head meta‑analysis f...

Jan 11, 2026

How do GLP‑1 weight‑loss medications differ mechanistically and clinically from appetite‑control food tricks like gelatin?

GLP‑1 receptor agonists are prescription drugs that mimic an endogenous gut hormone to alter brain and gut circuits, slow gastric emptying, improve glycemic control and produce clinically meaningful, ...

Jan 2, 2026

What proven, evidence‑based approaches exist for appetite control and modest weight loss?

Proven approaches to appetite control and modest weight loss combine behavioral strategies, evidence-based diets, physical activity, and—when appropriate—medical therapies; no single method fits every...

Dec 31, 2025

What clinical trials exist for tirzepatide and how do their weight‑loss results compare to over‑the‑counter supplements?

Tirzepatide is a prescription, once‑weekly injectable dual GIP/GLP‑1 receptor agonist studied across multiple phase 3 programs (SURPASS for diabetes and SURMOUNT for obesity) and meta‑analyses, produc...

Dec 2, 2025

Gelatin’s for weight loss

The “gelatin trick” is a viral pre‑meal ritual that involves dissolving unflavored or sugar‑free gelatin in hot water, chilling it into cubes or drinking it before it sets, and using those cubes to bl...

Nov 3, 2025

How does Barislend compare to other prescription weight loss medications?

BariSlend is marketed as a dietary supplement claiming to support weight loss through plant-based ingredients, but the available materials show with prescription anti-obesity drugs such as semaglutide...

Oct 20, 2025

Which celebrities have endorsed Lipomax and what are their results?

There is in the provided materials that any high-profile celebrity has publicly endorsed a product named "Lipomax" or reported results from using it; the dataset contains a single celebrity procedure ...